Southpoint Capital Advisors LP Has $189.54 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Southpoint Capital Advisors LP increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 30.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,600,000 shares of the company’s stock after buying an additional 600,000 shares during the quarter. Henry Schein accounts for about 4.5% of Southpoint Capital Advisors LP’s investment portfolio, making the stock its 7th largest position. Southpoint Capital Advisors LP owned 2.09% of Henry Schein worth $189,540,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Cromwell Holdings LLC increased its stake in shares of Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the period. Summit Securities Group LLC acquired a new stake in shares of Henry Schein in the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA acquired a new stake in shares of Henry Schein in the 2nd quarter valued at $37,000. Blue Trust Inc. increased its stake in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after buying an additional 475 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares during the period. Institutional investors own 96.62% of the company’s stock.

Analyst Ratings Changes

HSIC has been the subject of several research reports. Evercore ISI lifted their target price on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Robert W. Baird decreased their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. UBS Group decreased their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Finally, JPMorgan Chase & Co. decreased their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research note on Monday, August 12th. Six equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $79.38.

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $77.05 on Friday. The firm has a market cap of $9.61 billion, a price-to-earnings ratio of 31.71, a price-to-earnings-growth ratio of 2.23 and a beta of 0.87. The stock’s 50-day moving average is $71.36 and its 200-day moving average is $69.89. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The company had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.32 earnings per share. Equities analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Insider Activity

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. The trade was a 12.25 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.